A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This is a single-center, single-arm clinical study to evaluate the safety, tolerability,
dosimetry and preliminary efficacy of [177Lu]Lu-XT117 injection in patients with FAP-positive
advanced solid tumors.